𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rituximab in chronic lymphocytic leukemia

✍ Scribed by Danelle F. James; Thomas J. Kipps

Book ID
107648761
Publisher
Springer Healthcare Communications
Year
2011
Tongue
English
Weight
846 KB
Volume
28
Category
Article
ISSN
0741-238X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pentostatin, cyclophosphamide, and ritux
Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia
✍ Tait D. Shanafelt; Thomas Lin; Susan M. Geyer; Clive S. Zent; Nelson Leung; Bria 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Abstract ## BACKGROUND. The prevalence of chronic lymphocytic leukemia (CLL) increases with age. Although chemoimmunotherapy (CIT) has dramatically improved response rates in patients with CLL, some CIT regimens are not well tolerated by many patients ≥70 years of age. ## METHODS. Sixty‐four